National Centre for Disease Control – NCDC has expressed joy as the fund to tackle the current challenges around testing for coronavirus also known as COVID-19 set up by 54gene, African genomics research services reached $500,000 less than 24 hours of its launch on Thursday.
54gene opened the fund with a donation of $150,000 and within 24 hours an additional $350,000 was secured from partners including Union Bank.
According to Business Day, the genomics research service plans to utilise the fund by increasing the COVID-19 testing capacity in Nigeria by up to 1,000 additional tests a day.
To achieve this, the company will buy testing instruments and the required biosafety materials such as biosafety cabinets and personal protective equipment needed to keep frontline healthcare workers safe.
Working in unison with the NCDC and other stakeholders, 54gene’s team expects to start deploying the fund within days, purchasing vital testing equipment, to be used by medical professionals.
All equipment will be installed in public hospitals and laboratories across Nigeria, and will remain in situ once the current COVID-19 pandemic subsides, to be used by medical researchers and clinicians in case of any future outbreaks.
And the National Centre for Disease Control – NCDC has this to say;
“This is the kind of support we need. Identify a problem, run with it & include a sustainability plan in your solution. We’re very grateful for this new partnership with 54gene at a critical point in our health security,” @Chikwe_I, DG NCDC”#COVID19 https://t.co/9B8oWeNe8j
— NCDC (@NCDCgov) March 26, 2020
Source: Business Day